Amedisys Net Profit Margin 2010-2024 | AMED

Amedisys net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Amedisys Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $2.35B $0.04B 1.83%
2024-09-30 $2.32B $0.08B 3.53%
2024-06-30 $2.29B $0.09B 3.98%
2024-03-31 $2.25B $-0.02B -0.93%
2023-12-31 $2.24B $-0.01B -0.45%
2023-09-30 $2.23B $0.00B 0.13%
2023-06-30 $2.23B $0.00B 0.13%
2023-03-31 $2.23B $0.11B 5.06%
2022-12-31 $2.22B $0.12B 5.40%
2022-09-30 $2.22B $0.12B 5.50%
2022-06-30 $2.22B $0.14B 6.37%
2022-03-31 $2.23B $0.19B 8.58%
2021-12-31 $2.23B $0.21B 9.38%
2021-09-30 $2.23B $0.22B 9.89%
2021-06-30 $2.22B $0.25B 11.12%
2021-03-31 $2.16B $0.20B 9.35%
2020-12-31 $2.11B $0.18B 8.74%
2020-09-30 $2.05B $0.17B 8.15%
2020-06-30 $2.00B $0.13B 6.46%
2020-03-31 $1.98B $0.13B 6.46%
2019-12-31 $1.96B $0.13B 6.49%
2019-09-30 $1.89B $0.13B 6.67%
2019-06-30 $1.81B $0.12B 6.79%
2019-03-31 $1.73B $0.12B 7.05%
2018-12-31 $1.66B $0.12B 7.10%
2018-09-30 $1.63B $0.09B 5.35%
2018-06-30 $1.58B $0.07B 4.49%
2018-03-31 $1.55B $0.04B 2.72%
2017-12-31 $1.51B $0.03B 1.98%
2017-09-30 $1.46B $0.04B 2.94%
2017-06-30 $1.45B $0.04B 2.69%
2017-03-31 $1.44B $0.05B 3.20%
2016-12-31 $1.42B $0.04B 2.61%
2016-09-30 $1.41B $0.04B 2.91%
2016-06-30 $1.37B $0.04B 2.77%
2016-03-31 $1.33B $0.04B 2.86%
2015-12-31 $1.28B $0.00B -0.23%
2015-09-30 $1.24B $-0.01B -0.56%
2015-06-30 $1.22B $-0.01B -0.58%
2015-03-31 $1.21B $-0.01B -0.83%
2014-12-31 $1.21B $0.01B 1.08%
2014-09-30 $1.21B $-0.01B -0.50%
2014-06-30 $1.21B $-0.11B -8.69%
2014-03-31 $1.22B $-0.11B -9.11%
2013-12-31 $1.25B $-0.10B -7.69%
2013-09-30 $1.29B $-0.19B -14.97%
2013-06-30 $1.35B $-0.09B -6.80%
2013-03-31 $1.40B $-0.09B -6.15%
2012-12-31 $1.44B $-0.08B -5.83%
2012-09-30 $1.42B $0.03B 1.90%
2012-06-30 $1.42B $-0.41B -28.58%
2012-03-31 $1.43B $-0.39B -27.50%
2011-12-31 $1.42B $-0.38B -27.03%
2011-09-30 $1.46B $-0.37B -25.03%
2011-06-30 $1.49B $0.08B 5.43%
2011-03-31 $1.55B $0.09B 5.88%
2010-12-31 $1.60B $0.11B 7.06%
2010-09-30 $1.62B $0.13B 7.98%
2010-06-30 $1.60B $0.14B 8.94%
2010-03-31 $1.56B $0.15B 9.39%
2009-12-31 $1.48B $0.14B 9.16%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.109B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.927B 19.64
Encompass Health (EHC) United States $11.673B 24.77
DaVita (DVA) United States $10.879B 14.44
Chemed (CHE) United States $8.411B 26.43
Option Care Health (OPCH) United States $5.041B 22.40
Elanco Animal Health (ELAN) United States $4.836B 10.70
RadNet (RDNT) United States $3.906B 82.65
LifeStance Health (LFST) United States $2.551B 0.00
Addus HomeCare (ADUS) United States $1.893B 21.66
Astrana Health (ASTH) United States $1.747B 35.00
U.S Physical Therapy (USPH) United States $1.088B 27.75
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Pennant (PNTG) United States $0.897B 35.86
Atai Life Sciences (ATAI) Germany $0.282B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00